Origin is a biotech company that creates patient-derived cancer single-cell dataset for licensing to pharmaceutical and AI companies.
Origin's investors include Y Combinator.
Origin is headquartered in San Francisco, United States.
Origin is a biotech company that creates patient-derived cancer single-cell dataset for licensing to pharmaceutical and AI companies.
Origin is at the Pre-Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Origin — Funding & Investors." VCBacked, March 24, 2026, https://www.vcbacked.co/company/origin-san-francisco. Accessed October 21, 2026.
VCBacked. (2026). Origin — Funding & Investors. Retrieved October 21, 2026, from https://www.vcbacked.co/company/origin-san-francisco
{{cite web |title=Origin — Funding & Investors |url=https://www.vcbacked.co/company/origin-san-francisco |website=VCBacked |access-date=October 21, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated